PUBLICATIONS

Chercher par auteur :
Tous les AuteursAlcaraz GAmendola JAnkri NAziz AAzzaz FBaudot PBialowas ABoudkkazi SBoumedine NBrechet ACaillard OCampanac ECarlier EChahinian HCoq JOCudmore RHDaoudal GDe San Feliciano MDebanne DDebreux KDenis DDesplantes RDi Giovanni JDubruc FDufour MDuménieu MDéglise PEl Far OExtrémet JFantini JFormisano-Treziny CFronzaroli-Molinieres LFékété AGabert JGasselin CGastrein PGiraud PGoaillard JMHaddjeri-Hopkins AIborra CIncontro SInglebert YLEVEQUE CLopez CLévêque CMarcaggi PMarqueze BMarra VMaulet YMoubarak EMoutot NRama SRamirez-Franco JJRussier MSammari MSangiardi MSeagar MSourdet VTapia MTell FTemporal SUsseglio FWakade AWoodhouse AYahi NYoussouf FZanin EZbili M

Chercher par année de publication :
Toutes les Années2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987198619841983198219811980197919781974

Chercher par mot-clé :

	PUBLICATIONS
ACCUEIL   |  PUBLICATIONS

ANNEE : 2017

Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells.

AUTEURS : Connan C, Voillequin M, Chavez CV, Mazuet C1,, Lévêque C, Vitry S, Vandewalle A, Popoff MR.

REVUE : Cellular Microbiology

Botulinum neurotoxins (BoNTs) are responsible for severe flaccid paralysis by inhibiting the release of acetylcholine at the neuromuscular junctions. BoNT type B (BoNT/B) most often induces mild forms of botulism with predominant dysautonomic symptoms. In food borne botulism and botulism by intestinal colonisation such as infant botulism, which are the most frequent naturally acquired forms of botulism, the digestive tract is the main entry route of BoNTs into the organism. We previously showed that BoNT/B translocates through mouse intestinal barrier by an endocytosis-dependent mechanism and subsequently targets neuronal cells, mainly cholinergic neurons, in the intestinal mucosa and musculosa. Here, we investigated the entry pathway of BoNT/B using fluorescent C-terminal domain of the heavy chain (HcB), which is involved in the binding to specific receptor(s) and entry process into target cells. While the combination of gangliosides GD_1a /GD_1b /GT_1b and synaptotagmin I and to a greater extent synaptotagmin II constitutes the functional HcB receptor on NG108-15 neuronal cells, HcB only uses the gangliosides GD_1a /GD_1b /GT_1b to efficiently bind to m-IC_cl2 intestinal cells. HcB enters both cell types by a dynamin-dependent endocytosis, which is efficiently prevented by Dynasore, a dynamin inhibitor, and reaches a common early endosomal compartment labeled by early endosome antigen (EEA1). In contrast to neuronal cells, HcB uses a Cdc42-dependent pathway to enter intestinal cells. Then, HcB is transported to late endosomes in neuronal cells, whereas it exploits a nonacidified pathway from apical to basal lateral side of m-IC_cl2 cells supporting a transcytotic route in epithelial intestinal cells.